Tailor-made antibody therapeutics

被引：45

作者：

Chowdhury, PS ^{[1
]}

Wu, H ^{[1
]}

机构：

[1] Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA

来源：

METHODS | 2005年 / 36卷 / 01期

关键词：

therapeutic antibodies; antibody engineering; affinity maturation; effector functions; FcRn binding; antibody fragments; immunoconjugates; immunotoxins; immunocytokines; ADEPT; radio-labeled antibodies; Bi-specific antibodies; PEGylation;

D O I：

10.1016/j.ymeth.2005.01.002

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Therapeutic antibodies represent one of the fastest growing areas of the pharmaceutical industry. There are currently 18 monoclonal antibodies in the market that have been approved by the FDA and over 150 in clinical developments. Driven by innovation and technological developments, scientists have gone beyond the traditional antibody molecules. Antibodies have been engineered in a variety of ways to meet the challenges posed by different biological settings. Described in this review is an abridged account of the different ways antibodies have been tailored to make them efficient drug molecules. (c) 2005 Elsevier Inc. All rights reserved.

引用

页码：11 / 24

页数：14

共 97 条

[91] Stepwise in vitro affinity maturation of Vitaxin, an αvβ3-specific humanized mAb [J].

Wu, HR ;

Beuerlein, G ;

Nie, Y ;

Smith, H ;

Lee, BA ;

Hensler, M ;

Huse, WD ;

Watkins, JD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6037-6042

[92] A trivalent anti-erbB2/anti-CD16 bispecific antibody retargeting NK cells against human breast cancer cells [J].

Xie, ZG ;

Shi, M ;

Feng, JN ;

Yu, M ;

Sun, YX ;

Shen, BF ;

Guo, N .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 311 (02) :307-312

[93] CDR WALKING MUTAGENESIS FOR THE AFFINITY MATURATION OF A POTENT HUMAN ANTI-HIV-1 ANTIBODY INTO THE PICOMOLAR RANGE [J].

YANG, WP ;

GREEN, K ;

PINZSWEENEY, S ;

BRIONES, AT ;

BURTON, DR ;

BARBAS, CF .

JOURNAL OF MOLECULAR BIOLOGY, 1995, 254 (03) :392-403

[94]

Yao ZS, 2002, CANCER RES, V62, P5755

[95] Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning [J].

Zhang, MY ;

Shu, YU ;

Rudolph, D ;

Prabakaran, P ;

Labrijn, AF ;

Zwick, MB ;

Lal, RB ;

Dimitrov, DS .

JOURNAL OF MOLECULAR BIOLOGY, 2004, 335 (01) :209-219

[96]

Zhu ZP, 1997, PROTEIN SCI, V6, P781

[97] An efficient route to the production of an IgG-like bispecific antibody [J].

Zuo, Z ;

Jimenez, X ;

Witte, L ;

Zhu, ZP .

PROTEIN ENGINEERING, 2000, 13 (05) :361-367

← 1 2 3 4 5 6 7 8 9 10 →